Simplex Trading’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-4,123
| Closed | – | – | 4427 |
|
2025
Q1 | $0 | Buy |
+4,123
| New | – | ﹤0.01% | 4354 |
|
2024
Q4 | – | Hold |
0
| – | – | – | 4331 |
|
2024
Q3 | – | Sell |
-14,091
| Closed | -$72K | – | 4282 |
|
2024
Q2 | $72K | Buy |
14,091
+13,859
| +5,974% | +$70.8K | ﹤0.01% | 1246 |
|
2024
Q1 | $1K | Buy |
+232
| New | +$1K | ﹤0.01% | 2221 |
|
2023
Q4 | – | Hold |
0
| – | – | – | 4361 |
|
2023
Q3 | – | Hold |
0
| – | – | – | 4313 |
|
2023
Q2 | – | Sell |
-196
| Closed | – | – | 4348 |
|
2023
Q1 | $0 | Sell |
196
-1,093
| -85% | – | ﹤0.01% | 4383 |
|
2022
Q4 | $4K | Buy |
+1,289
| New | +$4K | ﹤0.01% | 2078 |
|
2022
Q3 | – | Sell |
-14
| Closed | – | – | 4527 |
|
2022
Q2 | $0 | Buy |
+14
| New | – | ﹤0.01% | 4497 |
|
2022
Q1 | – | Sell |
-39
| Closed | -$1K | – | 4507 |
|
2021
Q4 | $1K | Sell |
39
-4,473
| -99% | -$115K | ﹤0.01% | 2863 |
|
2021
Q3 | $255K | Sell |
4,512
-24
| -0.5% | -$1.36K | ﹤0.01% | 1187 |
|
2021
Q2 | $247K | Buy |
4,536
+2,231
| +97% | +$121K | ﹤0.01% | 1218 |
|
2021
Q1 | $172K | Buy |
2,305
+2,064
| +856% | +$154K | ﹤0.01% | 1173 |
|
2020
Q4 | $26K | Buy |
241
+232
| +2,578% | +$25K | ﹤0.01% | 1733 |
|
2020
Q3 | $0 | Buy |
+9
| New | – | ﹤0.01% | 3427 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 3300 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 3264 |
|
2019
Q4 | – | Sell |
-58
| Closed | -$6K | – | 3164 |
|
2019
Q3 | $6K | Sell |
58
-13
| -18% | -$1.35K | ﹤0.01% | 1574 |
|
2019
Q2 | $6K | Buy |
71
+19
| +37% | +$1.61K | ﹤0.01% | 1525 |
|
2019
Q1 | $4K | Sell |
52
-55
| -51% | -$4.23K | ﹤0.01% | 1579 |
|
2018
Q4 | $5K | Sell |
107
-49
| -31% | -$2.29K | ﹤0.01% | 1596 |
|
2018
Q3 | $18K | Buy |
156
+63
| +68% | +$7.27K | ﹤0.01% | 1553 |
|
2018
Q2 | $9K | Sell |
93
-152
| -62% | -$14.7K | ﹤0.01% | 1700 |
|
2018
Q1 | $31K | Sell |
245
-939
| -79% | -$119K | ﹤0.01% | 1289 |
|
2017
Q4 | $115K | Buy |
+1,184
| New | +$115K | ﹤0.01% | 918 |
|